[go: up one dir, main page]

NO20005146D0 - Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter - Google Patents

Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter

Info

Publication number
NO20005146D0
NO20005146D0 NO20005146A NO20005146A NO20005146D0 NO 20005146 D0 NO20005146 D0 NO 20005146D0 NO 20005146 A NO20005146 A NO 20005146A NO 20005146 A NO20005146 A NO 20005146A NO 20005146 D0 NO20005146 D0 NO 20005146D0
Authority
NO
Norway
Prior art keywords
thienylazolylalkoxyethanamines
drugs
preparation
Prior art date
Application number
NO20005146A
Other languages
English (en)
Other versions
NO20005146L (no
NO320313B1 (no
Inventor
Ramon Merce-Vidal
Blas Andaluz-Mataro
Jordi Frigola-Constansa
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of NO20005146D0 publication Critical patent/NO20005146D0/no
Publication of NO20005146L publication Critical patent/NO20005146L/no
Publication of NO320313B1 publication Critical patent/NO320313B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/41551,2-Diazoles non condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20005146A 1998-04-15 2000-10-13 Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter, samt farmasoytisk sammensetning som innbefatter dem NO320313B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009800793A ES2150353B1 (es) 1998-04-15 1998-04-15 Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
PCT/ES1999/000098 WO1999052525A1 (es) 1998-04-15 1999-04-15 Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos

Publications (3)

Publication Number Publication Date
NO20005146D0 true NO20005146D0 (no) 2000-10-13
NO20005146L NO20005146L (no) 2000-12-14
NO320313B1 NO320313B1 (no) 2005-11-21

Family

ID=8303465

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005146A NO320313B1 (no) 1998-04-15 2000-10-13 Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter, samt farmasoytisk sammensetning som innbefatter dem

Country Status (31)

Country Link
US (3) US6410582B1 (no)
EP (1) EP1072266B8 (no)
JP (1) JP2002511412A (no)
KR (1) KR100523366B1 (no)
CN (1) CN1189170C (no)
AR (1) AR016210A1 (no)
AT (1) ATE302604T1 (no)
AU (1) AU754705B2 (no)
BG (1) BG64891B1 (no)
BR (1) BR9910124A (no)
CA (1) CA2328878A1 (no)
CO (1) CO5011045A1 (no)
CU (1) CU22960A3 (no)
CZ (1) CZ298222B6 (no)
EE (1) EE04739B1 (no)
ES (1) ES2150353B1 (no)
GE (1) GEP20032913B (no)
HU (1) HUP0102585A3 (no)
IS (1) IS5662A (no)
LT (1) LT4830B (no)
LV (1) LV12624B (no)
NO (1) NO320313B1 (no)
NZ (1) NZ507573A (no)
PL (1) PL343512A1 (no)
RO (1) RO121690B1 (no)
RU (1) RU2213743C2 (no)
SI (1) SI20473A (no)
SK (1) SK285039B6 (no)
TW (1) TW528756B (no)
UA (1) UA58589C2 (no)
WO (1) WO1999052525A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2150353B1 (es) * 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137136B1 (es) * 1998-05-18 2000-07-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.
ES2150378B1 (es) * 1998-08-07 2001-07-01 Esteve Labor Dr Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p.
US6432954B1 (en) * 2000-07-14 2002-08-13 Targacept, Inc. Pharmaceutical compositions and methods for use
ES2174756B2 (es) * 2001-04-06 2003-11-16 Esteve Labor Dr Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias.
US20040142929A1 (en) * 2001-07-06 2004-07-22 Ramon Merce-Vidal Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
ES2180449B1 (es) * 2001-07-06 2004-01-16 Esteve Labor Dr Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.
CL2004001034A1 (es) 2003-05-14 2005-03-28 Teijin Pharma Ltd Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r
TW200533657A (en) * 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
EP1584335A3 (en) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol composition and an opioid
US20060040924A1 (en) * 2004-06-22 2006-02-23 Laboratorios Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of renal colic
EP1784178A1 (en) * 2004-07-30 2007-05-16 Laboratorios Del Dr. Esteve, S.A. Aryl (or heteroaryl) azolylcarbinols
EP1632227A1 (en) * 2004-09-07 2006-03-08 Laboratorios del Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction
EP1671968A1 (en) * 2004-12-17 2006-06-21 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
WO2006063860A2 (en) * 2004-12-17 2006-06-22 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
EP1674465A1 (en) * 2004-12-27 2006-06-28 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
WO2006069767A1 (en) * 2004-12-27 2006-07-06 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
ES2303795B1 (es) * 2004-12-27 2009-06-12 Laboratorios Del Dr. Esteve, S.A. Procedimiento para obtener enantiomeros de tienilazolilalcoxietanaminas.
EP1757587A1 (en) * 2005-07-15 2007-02-28 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743892A1 (en) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
US7897589B2 (en) * 2005-07-15 2011-03-01 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743890A1 (en) * 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments
US20070149590A1 (en) * 2005-08-05 2007-06-28 Garcia Francisco J L Controlled release dosage form of pirazole compounds
EP1820502A1 (en) 2006-02-10 2007-08-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising azolylcarbinol compounds
EP2151234A1 (en) * 2008-07-28 2010-02-10 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical formulation comprising a CB1-receptor compound in a solid solution and/or solid dispersion
CN102432845B (zh) * 2011-08-22 2013-03-13 电子科技大学 聚3,4-双乙基羟基噻吩气敏材料及其制备方法
WO2016096127A1 (en) * 2014-12-15 2016-06-23 Laboratorios Del Dr. Esteve, S.A. Methyl-1h-pyrazole alkylamine compounds having multimodal activity against pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2613720B1 (fr) * 1987-04-10 1990-01-19 Esteve Labor Dr Derives d'aryl-heteroaryl carbinols avec activite analgesique
RU2027716C1 (ru) * 1988-09-15 1995-01-27 Эбеве Арцнаймиттель ГмбХ Производные тиенилоксиалкиламина или их фармацевтически совместимые кислые аддитивные соли
RU2088573C1 (ru) * 1993-03-18 1997-08-27 Научно-исследовательский институт фармакологии РАМН 1-[w-(n,n-замещенные амино) алкил]-2-(2*991-ацилэтенил) пирролы или их фармацевтически приемлемые соли, обладающие антиаритмической и противоишемической активностью
ES2150353B1 (es) * 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137136B1 (es) * 1998-05-18 2000-07-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.

Also Published As

Publication number Publication date
NZ507573A (en) 2002-07-26
ATE302604T1 (de) 2005-09-15
BG64891B1 (bg) 2006-08-31
JP2002511412A (ja) 2002-04-16
LV12624B (lv) 2001-09-20
LT4830B (lt) 2001-08-27
US20020188017A1 (en) 2002-12-12
IS5662A (is) 2000-10-13
EP1072266A1 (en) 2001-01-31
RU2213743C2 (ru) 2003-10-10
ES2150353A1 (es) 2000-11-16
US6410582B1 (en) 2002-06-25
AR016210A1 (es) 2001-06-20
BR9910124A (pt) 2001-01-09
SK285039B6 (sk) 2006-05-04
BG104853A (en) 2001-04-30
ES2150353B1 (es) 2001-07-01
US7129361B2 (en) 2006-10-31
NO20005146L (no) 2000-12-14
AU3148399A (en) 1999-11-01
LT2000097A (en) 2001-03-26
SI20473A (sl) 2001-08-31
UA58589C2 (uk) 2003-08-15
RO121690B1 (ro) 2008-02-28
EP1072266B8 (en) 2006-10-18
KR20010042739A (ko) 2001-05-25
LV12624A (lv) 2001-03-20
AU754705B2 (en) 2002-11-21
SK15282000A3 (sk) 2001-12-03
EE04739B1 (et) 2006-12-15
HUP0102585A3 (en) 2002-04-29
NO320313B1 (no) 2005-11-21
KR100523366B1 (ko) 2005-10-20
CA2328878A1 (en) 1999-10-21
CN1303283A (zh) 2001-07-11
WO1999052525A1 (es) 1999-10-21
CU22960A3 (es) 2004-06-21
PL343512A1 (en) 2001-08-27
EP1072266B1 (en) 2005-08-24
GEP20032913B (en) 2003-03-25
US20040162324A1 (en) 2004-08-19
CZ20003764A3 (en) 2001-05-16
EE200000596A (et) 2002-06-17
CO5011045A1 (es) 2001-02-28
CZ298222B6 (cs) 2007-07-25
TW528756B (en) 2003-04-21
HUP0102585A2 (hu) 2001-12-28
CN1189170C (zh) 2005-02-16

Similar Documents

Publication Publication Date Title
NO20005146D0 (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
DK1095025T3 (da) Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
DK1083171T3 (da) Pyrazolinderivater, deres fremstilling og anvendelse som medikamenter
NO20011503D0 (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, deres fremstilling og anvendelse som anorektiske legemidler
NO20035298D0 (no) CDK-inhiberende pyrimider, deres fremstilling og deres anvendelse som legemidler
NO20015156L (no) 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
NO20014603D0 (no) Tienopyrimidinforbindelser, deres fremstilling og anvendelse
NO991815L (no) Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter
NO20024175D0 (no) Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
NO20006138D0 (no) Substituerte indolinoner, fremstilling og anvendelse derav som medikamenter
NO20011216L (no) Azetidinderivater, deres fremstilling og medikamenter inneholdende forbindelsene
NO20014702L (no) Diarylderivater og deres anvendelse som medikamenter
NO20025357D0 (no) Antranylamider og deres anvendelse som legemidler
DK1073672T3 (da) Antipicornavirale forbindelser, deres fremstilling og anvendelse
DK0770059T3 (da) Substituerede benzamidiner, deres fremstilling og deres anvendelse som lægemidler
NO20031838D0 (no) Benzokazinonderivater, deres fremstilling og anvendelse
DK1004592T3 (da) Nye erythromycinderivater, deres fremstilling og deres anvendelse som medikamenter
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO20016247D0 (no) Streptograminderivater, deres fremstilling og preparater inneholdende derivatene
NO20022022D0 (no) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
NO20024107L (no) Tienopyridin derivater, deres fremstilling og anvendelse
DK1086077T3 (da) Hidtil ukendte antiestrogener, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
NO20006479D0 (no) Tienopyridinforbindelser, deres fremstilling og anvendelse
NO20000066D0 (no) 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasoeytiske anvendelse
NO20012802D0 (no) Benzofuranderivater, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees
ERR Erratum

Free format text: I PATENTTIDENDE NR. 48/05 BLE PATENT NR. 320313 FEILAKTIG KUNNGJORT TRADT UT AV KRAFT PA GRUNN AV MANGLENDE BETALING AV ARSAVGIFT. PATENTET ER FORTSATT I KRAFT.